SI Insights is a consulting firm specializing in confidential intelligence services for the pharma, medtech, and healthcare industries. They offer a network of over 20,000 experts, providing comprehensive reports, continuous monitoring, and expert interviews to assist clients in decision-making. With extensive experience in primary research, they cover various aspects such as market access, sales force deployment, and brand positioning.

1. SI Insights
Evidence Based Intelligence |Broad Expert Connect |Pharma/MedTech/Healthcare

2. Confidential © SI Insights Mumbai, India
ARE YOU A CONSULTING FIRM,
SEARCHING FOR TRUSTED PARTNER?
Are you a consulting company
looking for a trusted partner who
can help you provide
comprehensive CI reports
catering to almost any topic in
Pharma, MedTech, or Healthcare
industry?
Do you want to connect with the
right industry expert (HCPs &
other Experts) who is confident in
candid opinion sharing or looking
out to moderate and transcribe the
interview?
You have reached to right
professionals; we have been
delivering such projects since
years and we are happy to
help.
We are a process driven firm that entirely understand the value of privacy. You can completely trust us as we keep things absolutely confidential.

3. Confidential © SI Insights Mumbai, India
YOU MIGHT
BE
INTERESTED
IN
KNOWING…
Management – Employee’s, Customer’s and Competitor’s perception about the
management and their track record
Culture – Employee Friendly, Growth Oriented
Quality – Quality of Products & People from customer’s eyes
Process – Training, Marketing Practices, Supply Chain, etc.
Customer Coverage – Customer’s reach, Frequency
Customer Acceptance – Brand Acceptance, Attitude towards Sales Reps
Employees Happiness Index – What they like/dislike
Earning – Salary/Incentive/Allowances
Recent Changes – Why changes and how it impacted
Others – Anything else that might help in decision making

4. Confidential © SI Insights Mumbai, India
OUR OFFERINGS FOR DECISION MAKERS
+ Over 20,000 Experts Network + Pharma CI-Continuous Monitoring + Pharma Sales Force Deployment + Generic Drug
Launch Intelligence
 Complete due diligence and intelligence services of the firm,
sales line, product, or competitors. We provide a comprehensive
report on the most recent (real-time basis) data, as we collect the
data from none other than the people working/worked with the
firm.
 You will be pleased to receive the findings as we bring the least
known facts with every minute detail. As we conduct the interview,
you can talk to our experts or listen to our conversation, or jump
in between to get clarity on specific topics. We bring the evidence
to what we say.

5. Confidential © SI Insights Mumbai, India
OUR EXPERT NETWORK
20,000+
Experts
Network
Pharma | MedTech | Healthcare
Experts | HCPs | KOLs | Across the
Specialty
Interview Moderation | Expert Recruitment
Govt. – Private Institutions/Hospitals
We have been working in this area since over 15 years and developed a relationship with respondents that helps in conducting the interview confidently
A widespread network of professionals of different profiles, experience level to meet specific
requirement
To conduct a
comprehensi
ve
Intelligence
from Primary
Research
standpoint

6. 28%
18%
12%
10%
8%
7%
5%
4%
3%
2%
2%
0% 5% 10% 15% 20% 25% 30%
Sales
Marketing
Others
Manufacturing
Procurement
Market Access
Export/Import
API
R&D
Medical
Regulatory
10%
15%
17%
22%
36%
CEO, MD, Founders,
Presidents
Top Management (BU
Head, General Manger,
Marketing Head)
Senior Management
(NSM, Product Managers)
Mid Management (ZSM,
RSM, ABM)
Entry Level (Associates,
MR)
Respondent’s Profile
Coverage of our Expert’s Network
OUR EXPERT NETWORK –
SEGMENTATION

7. Confidential © SI Insights Mumbai, India
OUR EXPERT NETWORK –
SEGMENTATION
Pharma Sales Marketing Regulatory Finance
Market
Access
Manufacturing
Sourcing and
Supply Chain
HCPs Institutions
Patient’s
Groups
National Sales
Manager
Marketing
Manager
Regulatory
Manager
Finance
Lead
Market
Access
Manager,
Lead
People from
various
departments,
QA, QC,
Packaging etc.
API
Vendors/Buyers
All the specialist
form top corporates
to govt to small
nursing homes
CGHS,
EISS
Patients of
different
therapeutic
conditions
Zonal Sales
Manager
Group Product
Manager
Regulatory
Executives
Finance
Manager
Key Account
Managers
R&D
Procurement
Personals
Advisory Boards
State
bodies
Patient
Advocacy
Regional Sales
Manager
New Product
Development
Manager
Finance
Executive
International
Business
Development
Regulatory
Logistics
Personals/Agenci
es
Advocacy Boards NHM Patient‘s NGO
Area
manager/Key
Account
manager
Product
Manager
C&F Agents,
Owners
Top KOLs of
different specialties
Influencers
Sales
Executive/MR
Product
Executive
Distributors/Stocki
sts/Chemist
Superspecialists
and Rare Disease
experts
We cover ~99% of stakeholders from Pharma, MedTech & Healthcare Industry

8. SI Insights
Sales Force
Deployment | New
Generic Product
Launch |
Continuous
Medical Event
Monitoring
Case Study

9. Confidential © SI Insights Mumbai, India
 Medical Communication
 Specialty – Indication – Messaging
 Promo Spend
 Critical Success Factors
 Key Challenges
 Sales Force Deployment
 FF Size (Hierarchy, State & City wise distribution)
 Salary – Incentive
 Coverage, Reach, Frequency
 Margin and Schemes
 Brand Value, Trade Vs. Institution
SALES FORCE DEPLOYMENT / BRAND
INTELLIGENCE
This offers complete brand monitoring from an intelligence point of view. To conduct such an elaborative research, we
interview several stakeholders such as Pharma Industry Professionals, HCPs, Distributors, Chemist, etc. While we cover
only deployment analysis in the US and EU our reports for the Indian market is elaborative that cover different
intelligence attributes such as:
Our Sales Force Deployment reports are based on primary research. We reconfirm the data points using our vast network across the
globe.
Case Study – Pharma Sales Force Deployment

10. Confidential © SI Insights Mumbai, India
Deployment across different
departments – US
Deployment across different
departments – EU
Case Study – Pharma Sales Force Deployment (Market Covered – US &
EU)
- We interviewed several experts working
in different departments to confirm the
deployment. In given two different projects,
we covered US and EU markets

11. Confidential © SI Insights Mumbai, India
Key Marketing Activities Remarks Avg. Spend
PPE Kits Distribution 75 Dr / MR / Bimonthly @ cost of 400/Kit XX
Sanitizers Distribution 150 Dr / MR / Bimonthly @ cost of 200/Bottle XX
Masks Distribution 300 Dr / Mr / Month @ cost of 10/Mask (for 10 months only) XX
Medical Essentials
Rs 5000 / MR / bimonthly was allocated to but the medical essentials for the doctors as
per the territory need
XX
Sanitizer Dispenser 25 Dr / MR / Qtr. @ cost of 1000/LED dispenser XX
Samples Distribution Samples worth Rs 1500 / MR / Month (for 10 months) XX
Webinars
In the initial phase of lock down it was 2 -3 / month @ cost of HO, later on from July
onwards it is 1/ month
XX
Marketing Spend
Coverage – Reach, Frequency
Sales
&
Sales
Force
Deployment
Salary, Incentive, Product Line & SF Hierarchy
Case Study – Brand Monitoring/Marketing Intelligence (Market Covered – India)

12. Confidential © SI Insights Mumbai, India
MEDICAL COMMUNICATION & BRAND
POSITIONING INTELLIGENCE
We typically cover the following key areas:
• Specialty wise brand positioning
• Complete brand communication by indication
• The Research study that supports the medical communication
• Intelligence on medium to deliver the communication such as visual aid,
electronically, or through print material, etc.
There were various incidences when marketing managers asked for such
evidence-based medical communications that we could successfully deliver
on a case-to-case basis also on a continuous monitoring basis
Case Study – Positioning and Medical Communication Intelligence (Market Covered
– India)

13. Confidential © SI Insights Mumbai, India
GENERIC DRUG LAUNCH INTELLIGENCE
• Generic Launch: Regulated Market
We worked on several situations and tracked down the generic drug
development process in multiple cases. One of the situations was; drug
patent was about to get expired and a pharma manufacturer wanted us to
evaluate the preparedness of generic players on the following points:
• Drug Development
• R&D Progress
• Regulatory Filling
Generally, such projects are based on continuous monitoring of the drug
development that goes for months. In this case, we worked with the client for
over 18 months and provided information on their R&D (stage of drug
development, issues occurred, estimated time to pass all the process)
Manufacturing (API procurement, manufacturing challenges, SKUs, Unit of
production, etc.) Regulatory approvals and stages, Business Development (
whom they are partnering to sell the product, timeline, etc.) Supply Chain
(API procurement, quantity, where they are shipping the product, which port).
SI Intel’s were very well received by the client’s team.
Case Study – Generic Drug Launch Intelligence (Market Covered –
Global)

14. Confidential © SI Insights Mumbai, India
CONTINUOUS MONITORING OF MEDICAL
EVENTS
There was a requirement to monitor Key conferences and
KOL engagement programs across the therapy area.
Since it was a continuous monitoring project, we stabilized
a strong network of respondents involving Advocacy and
Advisory boards, Conference associations, Various KOLs,
etc. to receive timely information.
It was an interesting project and the client was happy to
receive the updates. They appreciated the detailed finding
that not only talks about the events; but participant’s
information, sponsor details, and cost association at every
level was helpful.
Case Study – Continuous monitoring of medical events (Market Covered –
Global)

15. Confidential © SI Insights Mumbai, India
WHO WE ARE? WHAT WE DO? WHOM WE
WORK WITH?
Pharma | MedTech |
Healthcare
Clientele
Top Consulting Firms Investment Firms
We are a Pharma, MedTech, and Healthcare intelligence firm based in Mumbai & Pune, India. Over the years, we have worked on
hundreds of different projects and helped leaders form Pharma, Healthcare, Private Equity, MedTech, and big Consulting firms to
take an informed decision. Being a leading Pharma CI firm in India we have a strong foothold in the domestic market, whereas we
have worked in different markets such as the US, EU, Middle East, and APAC countries (except China) on different projects covering
specific CI needs. Our clientele includes:

16. CONTACT
Mr. Hanumant Singh | Director, SI-
Insights
d- +91 750 622 1809
e- h.singh@siinsights.com
w- https://siinsights.com
Thank You!